( en | de | ru )

 

Disambiguation

From post

копироватьудалитьдобавить публикацию в буфер
Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.

, , , , , и . BMC Cancer, (2007)
DOI: 10.1186/1471-2407-7-89

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

Ernst-Christian André

Helmut André

Achim André

Karl Wilhelm Andrée

Emil Andrée

 

Другие публикации лиц с тем же именем

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers., , , , , , , , , и 27 other автор(ы). Clin Cancer Res, 21 (8): 1904-1915 (апреля 2015)Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes., , , , , и . BMC Cancer, (2007)Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome., , , , , , , , , и . Clin Cancer Res, 12 (17): 5118--5128 (сентября 2006)Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification., , , , , , , , , и 4 other автор(ы). J Clin Oncol, 24 (31): 5070--5078 (ноября 2006)Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease., , , , , , , , , и 1 other автор(ы). Cancer Lett, 250 (2): 250--267 (июня 2007)Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR., , , , , , , , и . Clin Cancer Res, 14 (20): 6590--6601 (октября 2008)Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature., , , , , , , , , и 10 other автор(ы). Clin Cancer Res, 16 (5): 1532--1541 (марта 2010)The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models., , , , , , , , , и 193 other автор(ы). Nat Biotechnol, 28 (8): 827--838 (августа 2010)Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas., , , , , , , , , и 4 other автор(ы). Genome Biol, 9 (10): R150 (2008)Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients., , , , , , , , , и 2 other автор(ы). Clin Cancer Res, 12 (1): 131--138 (января 2006)